Thilo Schroeder, Director at Revolution Medicines, Inc. (RVMD), bought 84,725 shares at $24.59 ($2.1M) on 2022-03-25, disclosed to the SEC on 2022-03-29.
Open-market purchase of $2.1M RVMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.59 | 29,235 | $719K | 34.2% |
| 2 | $24.59 | 29,235 | $719K | 34.2% |
| 3 | $25.26 | 12,765 | $322K | 15.4% |
| 4 | $25.26 | 12,765 | $322K | 15.4% |
| 5 | $24.71 | 725 | $18K | 0.9% |
| Total | $24.79 avg | 84,725 |
| $2.1M |
| 100% |
| Filing → |
| RVMD | BUY | 2022-07-26 | $5.0M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |
| RVMD | BUY | 2022-03-21 | $6.8M | — | Filing → |